Park­er-backed can­cer sci­en­tists shine a light on an emerg­ing path­way in pan­cre­at­ic can­cer

A cou­ple of high-pro­file can­cer re­searchers at MD An­der­son backed by the Park­er In­sti­tute have been ex­plor­ing an ex­per­i­men­tal path­way that they be­lieve shows some …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA